Evidence mapPaperPMID 40204281Full record

ReviewAmerican journal of physiology. Cell physiology2025

Oxygen dynamics and delivery strategies to enhance beta cell replacement therapy.

Kuang-Ming Shang, Tomoharu Suzuki, Hiroyuki Kato, Taro Toyoda, Yu-Chong Tai, Hirotake Komatsu

Abstract readReview
In one paragraph

Review in American journal of physiology. Cell physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kuang-Ming ShangDepartment of Medical Engineering, California Institute of Technology, Pasadena, California, United States.ORCID 0000-0001-5065-7607
Tomoharu SuzukiDepartment of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
Hiroyuki KatoDivision of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, California, United States.
Taro ToyodaDepartment of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.ORCID 0000-0002-2948-0525
Yu-Chong TaiDepartment of Medical Engineering, California Institute of Technology, Pasadena, California, United States.
Hirotake KomatsuDivision of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, California, United States.ORCID 0000-0003-0876-4809

Funding

HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R03DK129958JDRF (JDRF International) 3-SRA-2021-1073-S-BJDRF (JDRF International) 3-SRA-2023-1425-S-BNIDDK NIH HHS R03 DK129958Nora Eccles Treadwell Foundation NA
6 · The paper itself

Abstract

Beta cell replacement therapy via pancreatic islet transplantation offers a promising treatment for type 1 diabetes as an alternative to insulin injections. However, posttransplantation oxygenation remains a critical challenge; isolated islets from donors lose vascularity and rely on slow oxygen diffusion for survival until revascularization occurs in the host tissue. This often results in significant hypoxia-induced acute graft loss. Overcoming the oxygenation barrier is crucial for advancing islet transplantation. This review is structured in three sections: the first examines oxygen dynamics in islet transplantation, focusing on factors affecting oxygen supply, including vascularity. It highlights oxygen dynamics specific to both transplant sites and islet grafts, with particular attention to extrahepatic sites such as subcutaneous tissue. The second section explores current oxygen delivery strategies, categorized into two main approaches: augmenting oxygen supply and enhancing effective oxygen solubility. The final section addresses key challenges, such as the lack of a clearly defined oxygen threshold for islet survival and the limited precision in measuring oxygen levels within small islet constructs. Recent advancements addressing these challenges are introduced. By deepening the understanding of oxygen dynamics and identifying current obstacles, this review aims to guide the development of innovative strategies for future research and clinical applications. These advancements are anticipated to enhance transplantation outcomes and bring us closer to a cure for type 1 diabetes.

Indexed as

Diabetes Mellitus, Type 1Insulin-Secreting CellsIslets of Langerhans TransplantationOxygenAnimalsGraft SurvivalHumansOxygenbeta cell replacement therapydiabetesoxygen consumptionoxygen dynamicspancreatic islet

Identifiers

PMID40204281
PMCPMC12151131

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.